INCREASING EFFICACY OF EZH2 INHIBITORS IN KIDNEY CANCER.

$161,967FY2025Defense Health AgencyDOD

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators

View source on USAspending →

INCREASING EFFICACY OF EZH2 INHIBITORS IN KIDNEY CANCER. · GrantIndex